31. Preoperative predictors of recurrence beyond Milan criteria in hepatocellular carcinoma patients treated with frontline liver resection. (March 2023) Authors: Pelizzaro, F.; Trevisani, F.; Vitale, A.; Cillo, U.; Piscaglia, F.; Missale, G.; Sangiovanni, A.; Foschi, F.G.; Cabibbo, G.; Caturelli, E.; Di Marco, M.; Azzaroli, F.; Brunetto, M.R.; Raimondo, G.; Vidili, G.; Guarino, M.; Gasbarrini, A.; Campani, C.; Svegliati-Baroni, G.; Giannini, E.G. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Prognostic and diagnostic role of VEGF-A and HIF-1α in hepatocellular carcinoma treated with chemoembolization. (February 2020) Authors: Peserico, G.; Pinto, E.; Sartori, A.; Imondi, A.; Pelizzaro, F.; Penzo, B.; Angonese, C.; Cillo, U.; A.Vitale, ; Trevisani, F.; Farinati, F. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma. (March 2023) Authors: Ielasi, L.; Tovoli, F.; Stefanini, B.; Tortora, R.; Magini, G.; Sacco, R.; Pressiani, T.; Trevisani, F.; Piscaglia, F.; Granito, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Prognostic impact of previous intraarterial treatment in patients with hcc treated with sorafenib. (March 2023) Authors: Stefanini, B.; Ielasi, L.; Pressiani, T.; Trevisani, F.; Sacco, R.; Gardini, A. Casadei; Magini, G.; Di Costanzo, G.G.; Granito, A.; Tovoli, F.; Piscaglia, F. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Prognostic relevance of stage migration in patients with hepatocellular carcinoma: A multicenter cohort study. (10th February 2016) Authors: Vitale, A.; Farinati, F.; Polacco, M.; Trevisani, F.; Cillo, U. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Prognostic role of platelets-to lymphocytes ratio (PLR) and neutrophils-to-lymphocytes ratio (NLR) in hepatocellular carcinoma patients. (March 2021) Authors: Pelizzaro, F.; Sartori, A.; Imondi, A.; Penzo, B.; Vitale, A.; Trevisani, F.; Farinati, F.; Italian Liver Cancer (ITA.LI.CA) group, on behalf of the Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Prognostication of hepatocellular carcinoma under sorafenib: external validation of the PROSASH-II model. (February 2020) Authors: Sansone, V.; Tovoli, F.; Casadei-Gardini, A.; Di Costanzo, G.G.; Magini, G.; Sacco, R.; Pressiani, T.; Trevisani, F.; Tortora, R.; Ielasi, L.; Granito, A. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma: efficacy, safety and prognostic factors. (March 2021) Authors: Tovoli, F.; Dadduzio, V.; De Lorenzo, S.; Rimassa, L.; Masi, G.; Iavarone, M.; Marra, F.; Garajova, I.; Brizzi, M.P.; Daniele, B.; Trevisani, F.; Messina, C.; Clemente, F. Di; Pini, S.; Cabibbo, G.; Granito, A.; Rizzato, M.D.; Zagonel, V.; Brandi, G.; Pressiani, T. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. RETRACTED: SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury. (3rd April 2014) Authors: Ferrandi, M.; Molinari, I.; Matafora, V.; Zerbini, G.; Trevisani, F.; Rastaldi, M.P.; Simonini, M.; Giardino, L.; Ferrari, P.; Manunta, P. Journal: Human molecular genetics Issue: Volume 23:Number 16(2014:Aug. 15) Page Start: 4371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Subtle changes of c-reactive protein and serum creatinine during the index hospitalization predict early readmission in patients with decompensated cirrhosis. (February 2020) Authors: Tufoni, M.; Zaccherini, G.; Bartoletti, M.; Baldassarre, M.; Antognoli, A.; Leoni, S.; Berardi, S.; Tamè, M.; Marconi, L.; Basigli, E.; Iannone, G.; Pratelli, D.; Domenicali, M.; Viale, P.; Trevisani, F.; Caraceni, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗